Rockwell Medical reported second quarter 2026 results driven by new customer acquisition in the Western U.S., increased volume from existing accounts, and disciplined pricing actions. Gross margin expanded to 18% due to improved operating efficiency and the activation of two new automated liquid production lines. The company reiterated its goal of achieving approximately 30% gross margins and over $100 million in annual net sales by 2029. Management confirmed the recent reverse stock split was a strategic move to regain Nasdaq compliance and attract institutional investors, and stated it will not be followed by a capital raise. The second quarter marked a return to positive operating cash flow of $2.1 million, including final payments for the Evoqua acquisition.
Rockwell Medical IncQ2 earnings beat with margin expansion and positive cash flow
NVIDIA Corporation